Inozyme Pharma, Inc.

Q2 2023 13F Holders

Symbol
INZY
CUSIP
45790W108
Type
Equity
Class
COM
Num filings
79
Total reported value, excl. options
$190 M
Manager Report Date Value ($000) Shares Option Type